AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trees, D. L.
Right arrow Articles by Knapp, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trees, D. L.
Right arrow Articles by Knapp, J. S.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, August 1998, p. 2103-2105, Vol. 42, No. 8
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Identification of Novel Mutation Patterns in the parC Gene of Ciprofloxacin-Resistant Isolates of Neisseria gonorrhoeae

David L. Trees,1,* Amy L. Sandul,1 William L. Whittington,2 and Joan S. Knapp1

Division of AIDS, STD, and TB Laboratory Research, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia,1 and Neisseria Reference Laboratory, Department of Medicine, University of Washington, Seattle, Washington2

Received 20 January 1998/Returned for modification 8 April 1998/Accepted 20 May 1998

Of 65 ciprofloxacin-resistant, clinical isolates of Neisseria gonorrhoeae, 5 isolates exhibited ParC mutations previously undescribed in the gonococcus. For isolates containing two ParC mutations (the Ser-87right-arrowIle and Glu-91right-arrowGly mutations and the Gly-85right-arrowCys and Arg116right-arrowLeu mutations) the MICs of ciprofloxacin (8.0 to 64.0 µg/ml) were higher than those for the isolate containing the single ParC mutation (Arg-116right-arrowLeu; MIC, 1.0 µg/ml).

* Corresponding author. Mailing address: Bacterial STD Branch, Mailstop G-39, Division of AIDS, STD, and TB Laboratory Research, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333. Phone: (404) 639-2134. Fax: (404) 639-3976. E-mail: dlt1{at}cdc.gov.

Antimicrobial Agents and Chemotherapy, August 1998, p. 2103-2105, Vol. 42, No. 8
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 1998 by the American Society for Microbiology. All rights reserved.